MedWatch

Coloplast disappoints pension firm: "The outcome doesn't please the company, the investors or the employees"

Danish pension firm Akademikerpension believed Coloplast would publicize tax payments around the globe, but was sorely disappointed when this turned out not to be the case. According to the pension firm, Coloplast has yet to provide a real argument against country-by-country reporting.

Photo: Coloplast / PR

When Danish pension firm Akademikerpension asked Coloplast's management whether something was stopping them from publicizing the firm's tax payments the world over, the pension firm, as an institutional investor, had the clear expectation of getting an answer.

The question was posed at a general assembly back in December 2020 in the shape of a shareholder proposal for more transparency in Coloplast's tax payments. One year later, at the latest general assembly on Dec. 2, 2021, the pension firm's head of responsible investments, Troels Børrild, had a follow-up question.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

CHMP to remove 100 generic medicines from market

Due to fraudulent clinical trials from a contract research organization, the EMA’s expert committee, the CHMP, is now suspending marketing approval authorizations for around 100 generic drugs on the market.

Further reading

Related articles

Latest news

See all jobs